WBAD Stock Overview Operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Walgreens Boots Alliance, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Walgreens Boots Alliance Historical stock prices Current Share Price US$3.27 52 Week High US$8.25 52 Week Low US$2.79 Beta 0.62 1 Month Change -26.05% 3 Month Change 10.87% 1 Year Change -57.65% 3 Year Change -79.85% 5 Year Change n/a Change since IPO -81.13%
Recent News & Updates
Bronstein, Gewirtz & Grossman LLC Files Class Action Lawsuit Against Walgreens Boots Alliance, Inc Feb 06
Alpha Modus Sues Walgreens for Patent Infringement, Strengthening Its Leadership in AI-Driven Retail Innovation Feb 04 Walgreens Boots Alliance Reportedly in Discussions with Sycamore Partners About A Deal Worth Up to $10 Billion
Walgreens Boots Alliance, Inc. to Report Q1, 2025 Results on Jan 09, 2025 Dec 06
Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 30, 2025 Dec 03
Walgreens Boots Alliance Declares Quarterly Dividend, Payable on December 12, 2024 Oct 25 See more updates
Bronstein, Gewirtz & Grossman LLC Files Class Action Lawsuit Against Walgreens Boots Alliance, Inc Feb 06
Alpha Modus Sues Walgreens for Patent Infringement, Strengthening Its Leadership in AI-Driven Retail Innovation Feb 04 Walgreens Boots Alliance Reportedly in Discussions with Sycamore Partners About A Deal Worth Up to $10 Billion
Walgreens Boots Alliance, Inc. to Report Q1, 2025 Results on Jan 09, 2025 Dec 06
Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 30, 2025 Dec 03
Walgreens Boots Alliance Declares Quarterly Dividend, Payable on December 12, 2024 Oct 25 Walgreens Boots Alliance, Inc. Expects to Close Approximately 1,200 Stores over the Next 3 Years with About 500 Targeted to Close in Fiscal 2025 Oct 18
Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2025 Oct 15
Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer Oct 07
Saxena White P.A. Files New Securities Fraud Class Action Lawsuit Against Walgreens Boots Alliance, Inc. and Certain of its Executives Sep 18
Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024 Sep 09
Walgreens Announces Executive Appointments Aug 19
Gross Law Firm Announces Lawsuit Against Walgreens Boots Alliance, Inc Jul 17 Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on September 12, 2024
Boots Chief Quits Reportedly After Walgreens' Sale Plan Stalls Jul 01
Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024 Jun 06
Walgreens Announces Launch of Walgreens Brand Naloxone HCI Nasal Spray May 16
Walgreens Reportedly Contacts Potential Buyers for £7 Billion Boots Drugstore Chain May 14
Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024 Apr 26 Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen Mar 09
Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024 Mar 05
Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer Feb 27 Walgreens Boots Alliance, Inc. Announces Executive Changes
Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors Jan 26
Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health Jan 24
Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on March 12, 2024 Jan 04 The Shareholder Commons, Inc Files a Notice of Exempt Solicitation to Walgreens Boots Alliance, Inc Dec 13
Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024 Dec 09
Walgreens Boots Alliance, Inc. to Report Q1, 2024 Results on Jan 04, 2024 Dec 08
Walgreens Boots Alliance Names Neal Sample Executive Vice President and Chief Information Officer Nov 02
Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2023 Oct 27
Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2024 Oct 13 Walgreens Boots Alliance, Inc. Appoints Tim Wentworth as Chief Executive Officer, Effective October 23, 2023
Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from S&P 100 Sep 18 Dicello Levitt Files Lawsuit Against Kenvue, Procter & Gamble, Glaxosmithkline, and Walgreens
Walgreens Boots Alliance, Inc. Announces CEO Changes Sep 03 Walgreens Boots Alliance, Inc. Announces CEO Changes Walgreens Boots Alliance, Inc. Announces Departure of James Kehoe as Executive Vice President Walgreens Boots Alliance Declares Quarterly Dividend, Payable on September 12, 2023
Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire 120 pharmacies in Texas, Louisiana and Arkansas from Brookshire Grocery Company. Jul 12
An unknown buyer acquired 6.004471% stake in Option Care Health, Inc. (NasdaqGS:OPCH) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for approximately $330 million. Jun 10 Walgreens Boots Alliance, Inc. to Report Q3, 2023 Results on Jun 27, 2023 Jun 06
Walgreens Boots Alliance Declares Quarterly Dividend, Payable on March 10, 2023 Jan 27
Walgreens Reportedly Weighs $2 Billion Sale of Pharmacy Automation Unit Jan 26
Walgreens Boots Alliance, Inc. Provides Sales Guidance for Fiscal 2023 Jan 06
Walgreens Boots Alliance, Inc. to Report Q1, 2023 Results on Jan 05, 2023 Dec 13
Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023 Dec 10 Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023 Walgreens Boots Alliance, Inc. Announces Resignation of William Foote, the Board Lead Independent Director
Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2022 Oct 28
Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into a definitive agreement to acquire remaining 45% stake in CareCentrix, Inc. for approximately $390 million. Oct 12
John Standley to Leave as Executive Vice President of Walgreens Boots Alliance, Inc. on November 1, 2022 Sep 22
Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire additional 30% stake in Shields Specialty Pharmacy Holdings, LLC from Welsh, Carson, Anderson & Stowe, Jack Shields & others for approximately $1.4 billion. Sep 21
Walgreens Boots Alliance, Inc. to Report Q4, 2022 Results on Oct 13, 2022 Sep 16
Walgreens Boots Alliance, Inc. Announces Executive Appointments Sep 09
Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) completed the acquisition of a 55% stake in CareCentrix, Inc. Sep 02
Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) completed the acquisition of a 55% stake in CareCentrix, Inc. Sep 01
Walgreens Boots Alliance, Inc. Names Alethia Jackson Senior Vice President, ESG and Chief DEI Officer Aug 31
Walgreens Boots Alliance, Inc. Announces Resignation of David J. Brailer as Member of the Board of Directors Aug 26
Jnd Legal Administration Announces A Class Action Lawsuit in the U.S. District Court for the District of Arizona Against Defendants Theranos, Inc., Walgreens Boots Alliance, Inc. and Walgreen Arizona Drug Company Jul 15
Walgreens Boots Alliance Increases Quarterly Dividend, Payable September 9, 2022 Jul 14
Walgreens Boots Alliance Concludes Strategic Review and Decides to Retain Ownership of Its Successful Boots Business Jun 29
Walgreens Launches Clinical Trial Business to Address Industrywide Access and Diversity Challenges and Redefine Patient Experience Jun 17
Walgreens Boots Alliance, Inc. to Report Q3, 2022 Results on Jun 30, 2022 Jun 03
Walgreens Reportedly Gives A Few Extra Days for Bidders to Firm Up Offers May 14
An unknown buyer acquired 2.9% stake in AmerisourceBergen Corporation (NYSE:ABC) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for $900 million. May 13 Walgreens Boots Alliance, Inc. Reaches Opioid Settlement with State of Florida
Walgreens Reportedly Sets Deadline for Bids in Boots Auction Apr 28
Reliance Industries Reportedly Studying Possible Bid for Walgreens' Boots Chain Apr 15
Private Equity Giant Reportedly Abandons Boots Takeover Mar 03
Walgreens Boots Alliance, Inc. Appoints Steven J. Shulman to Its Board of Directors Feb 03
Walgreens Boots Alliance Declares Quarterly Dividend, Payable on March 11, 2022 Jan 28
Bain and CVC Reportedly to Team Up for Boots Bid Jan 13
Oak Street Real Estate Capital, LLC acquired 1.68-acre property at 3600 Winter Garden Vineland Road in Winter Garden from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for $5.2 million. Sep 24
PLx Pharma Inc.’s VAZALORE to Launch in over 8,000 Walgreens Stores Nationwide in August Jul 20 Shareholder Returns WBAD AR Consumer Retailing AR Market 7D -3.0% 0.1% -0.6% 1Y -57.7% -14.4% 97.1%
See full shareholder returns
Return vs Market: WBAD underperformed the AR Market which returned 97.8% over the past year.
Price Volatility Is WBAD's price volatile compared to industry and market? WBAD volatility WBAD Average Weekly Movement 10.9% Consumer Retailing Industry Average Movement 5.8% Market Average Movement 7.0% 10% most volatile stocks in AR Market 9.9% 10% least volatile stocks in AR Market 5.1%
Stable Share Price: WBAD's share price has been volatile over the past 3 months compared to the AR market.
Volatility Over Time: WBAD's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of AR stocks.
About the Company Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S.
Show more Walgreens Boots Alliance, Inc. Fundamentals Summary How do Walgreens Boots Alliance's earnings and revenue compare to its market cap? WBAD fundamental statistics Market cap US$8.38b Earnings (TTM ) -US$8.83b Revenue (TTM ) US$150.41b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) WBAD income statement (TTM ) Revenue US$150.41b Cost of Revenue US$123.88b Gross Profit US$26.53b Other Expenses US$35.37b Earnings -US$8.83b
Last Reported Earnings
Nov 30, 2024
Earnings per share (EPS) -10.22 Gross Margin 17.64% Net Profit Margin -5.87% Debt/Equity Ratio 71.5%
How did WBAD perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/16 13:29 End of Day Share Price 2025/02/14 00:00 Earnings 2024/11/30 Annual Earnings 2024/08/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources Walgreens Boots Alliance, Inc. is covered by 49 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Christopher Graja Argus Research Company Samuel Hudson Atlantic Equities LLP Eric Coldwell Baird
Show 46 more analysts 